1. Home
  2. SHMD vs HOWL Comparison

SHMD vs HOWL Comparison

Compare SHMD & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCHMID Group N.V. Class A Ordinary Shares

SHMD

SCHMID Group N.V. Class A Ordinary Shares

HOLD

Current Price

$5.86

Market Cap

216.2M

Sector

N/A

ML Signal

HOLD

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$0.65

Market Cap

64.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHMD
HOWL
Founded
1864
2017
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
216.2M
64.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SHMD
HOWL
Price
$5.86
$0.65
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$6.50
AVG Volume (30 Days)
208.8K
851.9K
Earning Date
01-01-0001
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$85,165,542.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.86
$0.56
52 Week High
$6.70
$2.38

Technical Indicators

Market Signals
Indicator
SHMD
HOWL
Relative Strength Index (RSI) 63.97 32.32
Support Level $4.70 $0.61
Resistance Level $5.40 $0.74
Average True Range (ATR) 0.64 0.09
MACD 0.07 -0.03
Stochastic Oscillator 77.36 14.30

Price Performance

Historical Comparison
SHMD
HOWL

About SHMD SCHMID Group N.V. Class A Ordinary Shares

Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

Share on Social Networks: